226 related articles for article (PubMed ID: 33000264)
21. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
22. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
Miyata Y; Sato T; Ito A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
[TBL] [Abstract][Full Text] [Related]
23. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells.
Kim JH; Park B
Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387
[TBL] [Abstract][Full Text] [Related]
24. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
25. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
26. Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway.
Kim MJ; Lee TH; Kim SH; Choi YJ; Heo J; Kim YH
Int J Oncol; 2010 Nov; 37(5):1177-85. PubMed ID: 20878065
[TBL] [Abstract][Full Text] [Related]
27. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
28. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
29. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
[TBL] [Abstract][Full Text] [Related]
30. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
31. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway.
Yang Y; Ye Y; Qiu Q; Xiao Y; Huang M; Shi M; Liang L; Yang X; Xu H
Int Immunopharmacol; 2016 Dec; 41():8-16. PubMed ID: 27816728
[TBL] [Abstract][Full Text] [Related]
33. Triptolide Suppressed the Microglia Activation to Improve Spinal Cord Injury Through miR-96/IKKβ/NF-κB Pathway.
Huang Y; Zhu N; Chen T; Chen W; Kong J; Zheng W; Ruan J
Spine (Phila Pa 1976); 2019 Jun; 44(12):E707-E714. PubMed ID: 31150368
[TBL] [Abstract][Full Text] [Related]
34. Duck enteritis virus activates CaMKKβ-AMPK to trigger autophagy in duck embryo fibroblast cells via increased cytosolic calcium.
Yin H; Zhao L; Wang Y; Li S; Huo H; Chen H
Virol J; 2018 Aug; 15(1):120. PubMed ID: 30081955
[TBL] [Abstract][Full Text] [Related]
35. [Effects of triptolide on the activity of TM3 Leydig cells and AMPK/Akt/mTOR pathway].
Ye XY; Chen L
Zhonghua Nan Ke Xue; 2019 Sep; 25(9):787-791. PubMed ID: 32233204
[TBL] [Abstract][Full Text] [Related]
36. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.
Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS
Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550
[TBL] [Abstract][Full Text] [Related]
37. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
38. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon.
Liu Y; Song F; Wu WK; He M; Zhao L; Sun X; Li H; Jiang Y; Yang Y; Peng K
Cell Biochem Funct; 2012 Jun; 30(4):271-8. PubMed ID: 22315045
[TBL] [Abstract][Full Text] [Related]
39. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis.
Tan BJ; Chiu GN
Int J Oncol; 2013 May; 42(5):1605-12. PubMed ID: 23467622
[TBL] [Abstract][Full Text] [Related]
40. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
